Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 3
1998 1
1999 3
2000 3
2002 2
2009 1
2011 1
2012 3
2014 1
2018 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
The use of recombinant antibodies in proteomics.
Holt LJ, Enever C, de Wildt RM, Tomlinson IM. Holt LJ, et al. Among authors: de wildt rm. Curr Opin Biotechnol. 2000 Oct;11(5):445-9. doi: 10.1016/s0958-1669(00)00133-6. Curr Opin Biotechnol. 2000. PMID: 11024361 Review.
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies.
Scott MJ, Jowett A, Orecchia M, Ertl P, Ouro-Gnao L, Ticehurst J, Gower D, Yates J, Poulton K, Harris C, Mullin MJ, Smith KJ, Lewis AP, Barton N, Washburn ML, de Wildt R. Scott MJ, et al. Among authors: de wildt r. MAbs. 2020 Jan-Dec;12(1):1755069. doi: 10.1080/19420862.2020.1755069. MAbs. 2020. PMID: 32343620 Free PMC article.
Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury.
Proudfoot A, Bayliffe A, O'Kane CM, Wright T, Serone A, Bareille PJ, Brown V, Hamid UI, Chen Y, Wilson R, Cordy J, Morley P, de Wildt R, Elborn S, Hind M, Chilvers ER, Griffiths M, Summers C, McAuley DF. Proudfoot A, et al. Among authors: de wildt r. Thorax. 2018 Aug;73(8):723-730. doi: 10.1136/thoraxjnl-2017-210305. Epub 2018 Jan 29. Thorax. 2018. PMID: 29382797 Free PMC article. Clinical Trial.
20 results